Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors

Mofarej Al-Hogbani; Jérémie Duguay; Daniel Christoph Wagner; Axel Haferkamp; Philippe Joubert; Sebastian Frees; Ricardo Rendon; Nicholas Power; Martine Périgny; Paul Toren

doi:10.1016/j.urolonc.2021.02.014

Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors

Mofarej Al-Hogbani, Jérémie Duguay, Daniel Christoph Wagner, Axel Haferkamp, Philippe Joubert, Sebastian Frees, Ricardo Rendon, Nicholas Power, Martine Périgny, Paul Toren

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	303.e1-303.e8
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	39
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2021.02.014
Publication status	Published - May 2021
Externally published	Yes

ASJC Scopus Subject Areas

Urology
Oncology

Keywords

Chemotherapy
Germ cell tumor
Immunohistochemistry
Programmed death ligand 1
Testis cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urolonc.2021.02.014

Cite this

Al-Hogbani, M., Duguay, J., Wagner, D. C., Haferkamp, A., Joubert, P., Frees, S., Rendon, R., Power, N., Périgny, M., & Toren, P. (2021). Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors. Urologic Oncology: Seminars and Original Investigations, 39(5), 303.e1-303.e8. https://doi.org/10.1016/j.urolonc.2021.02.014

Al-Hogbani, M, Duguay, J, Wagner, DC, Haferkamp, A, Joubert, P, Frees, S, Rendon, R, Power, N, Périgny, M & Toren, P 2021, 'Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors', Urologic Oncology: Seminars and Original Investigations, vol. 39, no. 5, pp. 303.e1-303.e8. https://doi.org/10.1016/j.urolonc.2021.02.014

@article{90a45a6d84fa43fa9727b0dccc1cfeff,

title = "Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors",

keywords = "Chemotherapy, Germ cell tumor, Immunohistochemistry, Programmed death ligand 1, Testis cancer",

author = "Mofarej Al-Hogbani and J{\'e}r{\'e}mie Duguay and Wagner, {Daniel Christoph} and Axel Haferkamp and Philippe Joubert and Sebastian Frees and Ricardo Rendon and Nicholas Power and Martine P{\'e}rigny and Paul Toren",

note = "Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = may,

doi = "10.1016/j.urolonc.2021.02.014",

language = "English",

volume = "39",

pages = "303.e1--303.e8",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors

AU - Al-Hogbani, Mofarej

AU - Duguay, Jérémie

AU - Wagner, Daniel Christoph

AU - Haferkamp, Axel

AU - Joubert, Philippe

AU - Frees, Sebastian

AU - Rendon, Ricardo

AU - Power, Nicholas

AU - Périgny, Martine

AU - Toren, Paul

PY - 2021/5

Y1 - 2021/5

KW - Chemotherapy

KW - Germ cell tumor

KW - Immunohistochemistry

KW - Programmed death ligand 1

KW - Testis cancer

UR - http://www.scopus.com/inward/record.url?scp=85102078483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102078483&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2021.02.014

DO - 10.1016/j.urolonc.2021.02.014

M3 - Article

C2 - 33685799

AN - SCOPUS:85102078483

SN - 1078-1439

VL - 39

SP - 303.e1-303.e8

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

Expression of programmed death ligand-1 (PD-L1) in metastatic and postchemotherapy viable testicular germ cell tumors

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this